Long reads. Honest medicine.
Clinical perspective on longevity, metabolic health, hormones, and the science behind the IHS Wellness protocols.
What GLP-1 Medications Actually Do to Your Body — And What They Don't
Semaglutide and tirzepatide are the most discussed medications in metabolic medicine right now. Here is what the clinical evidence actually says — and what the marketing doesn't tell you.
ReadThe Case for Peptide Bioregulators in Longevity Medicine
Dr. Vladimir Khavinson's decades of research on peptide bioregulators have produced results that are difficult to ignore. A clinical overview.
ReadWhy Muscle Mass Is the Most Important Longevity Biomarker You're Not Tracking
Sarcopenia — the age-related loss of muscle — is one of the strongest predictors of all-cause mortality. Here is what the data shows.
ReadHormone Replacement Therapy After 50: Separating the Evidence from the Fear
The Women's Health Initiative study scared a generation of physicians away from HRT. The follow-up research tells a different story.
ReadRed Light Therapy: What It Actually Does at the Cellular Level
The mechanism behind red light therapy is better understood than its reputation suggests. A breakdown of the photobiomodulation research.
Read